Symptomatic awareness of hypoglycemia may be less pronounced in patients with longstanding diabetes, in patients with diabetic nerve disease, in patients using medications that block the sympathetic nervous system (e.g., beta-blockers) [see Drug Interactions (7.1)], or in patients who experience recurrent hypoglycemia
A.VallabhaneniS.FarooqiJ.ChowdharyA.GovenderN
Conclusions First, it is too early to conclude that advancing type 2 diabetes is characterised by a progressive loss of the potential to secrete GLP-1 as part of the process of disease progression
This decision depends on individual health status, goals achieved, habits established, and presence of obesity-related conditions
Gpx1 modulates Con A-induced CD4+ T cell in the spleen In Con A-induced hepatic injury, T cells can be classified into two groups such as exogenous and endogenous
Interactions between the microbiota, immune and nervous systems in health and disease